|
|
Volumn 31, Issue 7, 2012, Pages 780-782
|
|
Highly sensitized patients in cardiac transplantation: Early outcomes from the Canadian Prioritized Organ Sharing Program
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BASILIXIMAB;
CORTICOSTEROID;
HLA ANTIGEN;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PANEL REACTIVE ANTIBODY;
PREDNISONE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ADULT;
BLOOD GROUP O;
CANADA;
CARDIAC ALLOGRAFT VASCULOPATHY;
CARDIAC GRAFT REJECTION;
CARDIOVASCULAR MORTALITY;
CLINICAL ARTICLE;
COST EFFECTIVENESS ANALYSIS;
DESENSITIZATION;
DIALYSIS;
ECHOCARDIOGRAPHY;
FEMALE;
FLOW CYTOMETRY;
FOLLOW UP;
GRAFT FAILURE;
GRAFT RECIPIENT;
HEALTH PROGRAM;
HEART DISEASE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART MUSCLE ISCHEMIA;
HEART TRANSPLANTATION;
HUMAN;
KIDNEY FAILURE;
KIDNEY GRAFT;
LEFT VENTRICULAR ASSIST DEVICE;
LETTER;
LIVER DYSFUNCTION;
MALE;
NEUROLOGICAL COMPLICATION;
OUTCOME ASSESSMENT;
PLASMAPHERESIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SURVIVAL;
TREATMENT OUTCOME;
ADULT;
CANADA;
FEMALE;
GRAFT REJECTION;
HEART TRANSPLANTATION;
HISTOCOMPATIBILITY TESTING;
HLA ANTIGENS;
HUMANS;
IMMUNIZATION;
MALE;
MIDDLE AGED;
OUTCOME ASSESSMENT (HEALTH CARE);
RETROSPECTIVE STUDIES;
RISK FACTORS;
TISSUE AND ORGAN PROCUREMENT;
WAITING LISTS;
|
|
EID: 84861903977
PISSN: 10532498
EISSN: 15573117
Source Type: Journal
DOI: 10.1016/j.healun.2012.02.017 Document Type: Letter |
|
Times cited : (12)
|
|
References (6)
|
